Artificial Intelligence (AI) is revolutionizing the Pharma industry by accelerating 𝐝𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐞𝐬.

Some of the key areas that are making development time reduction possible are: 

• Analyzing vast datasets, improving accuracy and speed. 

• Efficient patient recruitment and optimized trial designs. 

• Prediction of compound properties, facilitating more efficient development.

• Navigating regulatory approvals by forecasting potential hurdles and suggesting optimal pathways. 
  

Collectively, these advancements lead to a more efficient, cost-effective drug development process, ultimately expediting the delivery of life-saving drugs to patients.

You can read more on Forbs: https://bit.ly/4bP6Q3X